[News release – not published yet] COVID-19 outpatient thrombosis prevention trial ends early – “Results suggest that not treating certain symptomatic but stable outpatients with anticoagulant or antiplatelet therapy may be the best course of action”.
NIH ACTIV-4B COVID-19 outpatient thrombosis prevention trial ends earl – Brigham and Women’s Hospital Commentary: Antithrombotics No Help for Stable COVID-19 Outpatients: ACTIV-4b – TCTMD
The post [News release – not published yet] COVID-19 outpatient thrombosis prevention trial ends early – “Results suggest that not treating certain symptomatic but stable outpatients with anticoagulant or antiplatelet therapy may be the best course of action”. appeared first on Links Medicus.
Case report: Multisystem inflammatory syndrome in an adult after SARS-CoV-2 infection.
Multisystem inflammatory syndrome in an adult after SARS-CoV-2 infection – Canadian Medical Association Journal Commentary: COVID-19-related multisystem inflammatory syndrome in adults: Rare but possible – Canadian Medical Association Journal
The post Case report: Multisystem inflammatory syndrome in an adult after SARS-CoV-2 infection. appeared first on Links Medicus.
Ivermectin is the new hydroxychloroquine, take 2 – “Ivermectin shouldn’t be used to treat COVID-19 outside of the context of a well-designed clinical trial”.
Ivermectin is the new hydroxychloroquine, take 2 – Science-Based Medicine Related: [Preprint] Meta-analysis of RCT: Ivermectin for the treatment of COVID-19 – no effect on all-cause mortality, length of stay, or viral clearance AND M-A: Prophylaxis against Covid-19: 1 – no benefit from Hydroxychloroquine; 2 – as studies on ivermectin so far have been small, […]
The post Ivermectin is the new hydroxychloroquine, take 2 – “Ivermectin shouldn’t be used to treat COVID-19 outside of the context of a well-designed clinical trial”. appeared first on Links Medicus.
Perspective | COVID-19: The rise and rise of Delta.
COVID-19: The rise and rise of Delta – Sciblogs
The post Perspective | COVID-19: The rise and rise of Delta. appeared first on Links Medicus.
[Preprint] Rapid displacement of SARS-CoV-2 variant B.1.1.7 (Alpha) by B.1.617.2 (Delta) and P.1 (Gamma) in the United States.
Rapid displacement of SARS-CoV-2 variant B.1.1.7 by B.1.617.2 and P.1 in the United States – medRxiv Commentary on Twitter ???Preprint?B.1.617.2 Delta and P.1 are growing faster than B.1.1.7 & B.1.617.2 is growing faster than P.1 in the US?B.1.617.2 will soon be the dominant variant in the US?B.1.617.2 is growing more rapidly in counties with […]
The post [Preprint] Rapid displacement of SARS-CoV-2 variant B.1.1.7 (Alpha) by B.1.617.2 (Delta) and P.1 (Gamma) in the United States. appeared first on Links Medicus.
Review: Advances in the diagnosis and treatment of primary ciliary dyskinesia.
Advances in the Diagnosis and Treatment of Primary Ciliary Dyskinesia: A Review – JAMA Otolaryngology – Head & Neck Surgery (free for a limited period)
The post Review: Advances in the diagnosis and treatment of primary ciliary dyskinesia. appeared first on Links Medicus.
RCT: Routine use of prophylactic postoperative continuous positive airway pressure (CPAP) does not prevent pneumonia, re-intubation, and death after major abdominal surgery.
Postoperative continuous positive airway pressure to prevent pneumonia, re-intubation, and death after major abdominal surgery (PRISM): a multicentre, open-label, randomised, phase 3 trial – The Lancet Respiratory Medicine (link to abstract – $ for full-text) Commentary on Twitter (thread – click for more) Published today in @LancetRespirMed is the final report of @prismtrial, an […]
The post RCT: Routine use of prophylactic postoperative continuous positive airway pressure (CPAP) does not prevent pneumonia, re-intubation, and death after major abdominal surgery. appeared first on Links Medicus.
M-A: Azithromycin does not reduce the need for invasive mechanical ventilation or mortality in patients with Covid-19.
Efficacy and safety of azithromycin in Covid-19 patients: A systematic review and meta-analysis of randomized clinical trials – Reviews in Medical Virology
The post M-A: Azithromycin does not reduce the need for invasive mechanical ventilation or mortality in patients with Covid-19. appeared first on Links Medicus.
Concerned about the latest AstraZeneca news? These 3 graphics help you make sense of the risk – “Two people in Australia have died from thrombosis with thrombocytopenia after 3.8 million doses of the AstraZeneca vaccine delivered”.
Concerned about the latest AstraZeneca news? These 3 graphics help you make sense of the risk – The Conversation
The post Concerned about the latest AstraZeneca news? These 3 graphics help you make sense of the risk – “Two people in Australia have died from thrombosis with thrombocytopenia after 3.8 million doses of the AstraZeneca vaccine delivered”. appeared first on Links Medicus.
Increased transmissibility and global spread of SARS-CoV-2 variants of concern – “Estimated transmissibility increases of alpha 29% (95% CI: 24–33), beta 25% (95% CI: 20–30), gamma 38% (95% CI: 29–48) & delta 97% (95% CI: 76–117)”.
Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021 – Eurosurveillance Commentary on Twitter NEW publication in Eurosurveillance Increased transmissibility & global spread of #SARSCoV2 VOC & VOI Estimated transmissibility increases of alpha 29% (95% CI: 24–33), beta 25% (95% CI: 20–30), gamma 38% (95% CI: 29–48) & delta […]
The post Increased transmissibility and global spread of SARS-CoV-2 variants of concern – “Estimated transmissibility increases of alpha 29% (95% CI: 24–33), beta 25% (95% CI: 20–30), gamma 38% (95% CI: 29–48) & delta 97% (95% CI: 76–117)”. appeared first on Links Medicus.